Javascript must be enabled to continue!
BIN1 overexpression rescues cardiac but not skeletal muscle defects in a mouse model of caveolinopathy
View through CrossRef
ABSTRACT
Background
Mutations in
CAV3
, encoding caveolin-3, cause caveolinopathies, rare genetic disorders affecting both skeletal and cardiac muscle. Caveolin-3 contributes to T-tubule formation and excitation-contraction coupling. BIN1 (amphiphysin 2), a membrane-shaping protein critical for T-tubule integrity, has shown therapeutic promise in congenital myopathies and heart dysfunction. To date, there are no therapy for caveolinopathies.
Methods
We evaluated the therapeutic impact of BIN1 overexpression in
Cav-3
knockout mice, a model recapitulating key features of human caveolinopathy. We assessed skeletal and cardiac function, T-tubule morphology, mitochondria, and gene expression using histological, physiological, and molecular approaches.
Results
We found
Cav-3
-/-
mice displayed skeletal muscle weakness, T-tubule disorganization, and mitochondrial abnormalities, alongside cardiac diastolic dysfunction and myofibrillar disarray. While BIN1 overexpression failed to improve skeletal muscle strength, T-tubule structure, or fiber atrophy, it corrected nuclear positioning and partially restored mitochondrial markers. In contrast, BIN1 robustly rescued cardiac performance, restoring end-diastolic volume, cardiac output, and sarcomeric integrity. Expression profiling revealed greater dysregulation of excitation-contraction coupling and atrogene pathways in skeletal than in cardiac muscle. Cavin-4, a BIN1-interacting protein, was selectively dysregulated in
Cav3-/-
muscle, suggesting a mechanistic barrier to BIN1-mediated rescue in this tissue.
Conclusions
These findings identify tissue-specific differences in the molecular consequences of caveolin-3 loss and demonstrate that BIN1 overexpression effectively rescues cardiac, but not skeletal, manifestations of caveolinopathy. Our results support BIN1 as a promising gene therapy target for inherited cardiomyopathies, while highlighting the need for alternative strategies in skeletal muscle.
Title: BIN1 overexpression rescues cardiac but not skeletal muscle defects in a mouse model of caveolinopathy
Description:
ABSTRACT
Background
Mutations in
CAV3
, encoding caveolin-3, cause caveolinopathies, rare genetic disorders affecting both skeletal and cardiac muscle.
Caveolin-3 contributes to T-tubule formation and excitation-contraction coupling.
BIN1 (amphiphysin 2), a membrane-shaping protein critical for T-tubule integrity, has shown therapeutic promise in congenital myopathies and heart dysfunction.
To date, there are no therapy for caveolinopathies.
Methods
We evaluated the therapeutic impact of BIN1 overexpression in
Cav-3
knockout mice, a model recapitulating key features of human caveolinopathy.
We assessed skeletal and cardiac function, T-tubule morphology, mitochondria, and gene expression using histological, physiological, and molecular approaches.
Results
We found
Cav-3
-/-
mice displayed skeletal muscle weakness, T-tubule disorganization, and mitochondrial abnormalities, alongside cardiac diastolic dysfunction and myofibrillar disarray.
While BIN1 overexpression failed to improve skeletal muscle strength, T-tubule structure, or fiber atrophy, it corrected nuclear positioning and partially restored mitochondrial markers.
In contrast, BIN1 robustly rescued cardiac performance, restoring end-diastolic volume, cardiac output, and sarcomeric integrity.
Expression profiling revealed greater dysregulation of excitation-contraction coupling and atrogene pathways in skeletal than in cardiac muscle.
Cavin-4, a BIN1-interacting protein, was selectively dysregulated in
Cav3-/-
muscle, suggesting a mechanistic barrier to BIN1-mediated rescue in this tissue.
Conclusions
These findings identify tissue-specific differences in the molecular consequences of caveolin-3 loss and demonstrate that BIN1 overexpression effectively rescues cardiac, but not skeletal, manifestations of caveolinopathy.
Our results support BIN1 as a promising gene therapy target for inherited cardiomyopathies, while highlighting the need for alternative strategies in skeletal muscle.
Related Results
Alzheimer’s disease BIN1 coding variants increase intracellular Aβ by interfering with BACE1 recycling
Alzheimer’s disease BIN1 coding variants increase intracellular Aβ by interfering with BACE1 recycling
ABSTRACT
Genetics identified
BIN1
as the second most important risk locus associated with late-onset Alzheime...
Proteomic characterization of the Alzheimer’s disease risk factor BIN1 interactome
Proteomic characterization of the Alzheimer’s disease risk factor BIN1 interactome
Abstract
The gene
BIN1
is the second-largest genetic risk factor for late-onset Alzheimer’s disease (LOAD). I...
Poster 247: Muscle ERRγ Overexpression Mitigates the Muscle Atrophy after ACL injury
Poster 247: Muscle ERRγ Overexpression Mitigates the Muscle Atrophy after ACL injury
Objectives:
Anterior cruciate ligament (ACL) reconstruction is the 6th most common orthopedic procedure performed in the United States (1,2). There is substanti...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Link of BIN1, CLU, and fIDE Gene Polymorphisms with the Susceptibility
of Alzheimer’s Disease: Evidence from a Meta-analysis
Link of BIN1, CLU, and fIDE Gene Polymorphisms with the Susceptibility
of Alzheimer’s Disease: Evidence from a Meta-analysis
Background:
Alzheimer’s disease (AD) is the most common form of neurodegenerative disorder.
The association of BIN1, CLU, and IDE genetic polymorphisms with AD risk have been evalu...
BIN1 knockdown rescues systolic dysfunction in the aging heart
BIN1 knockdown rescues systolic dysfunction in the aging heart
Abstract
Cardiac dysfunction is a hallmark of aging in humans and mice. Here we report that a two-week treatment to restore youthful Bridging Int...
Dynamin-2 Phosphorylation as A Critical Regulatory Target of Bin1 and GSK3α for Endocytosis in Muscle
Dynamin-2 Phosphorylation as A Critical Regulatory Target of Bin1 and GSK3α for Endocytosis in Muscle
ABSTRACT
Tight regulation of endocytosis ensures accurate control of cellular signaling and membrane dynamics, which are crucial for tissue morph...
Insulin Signaling Attenuates GLUT4 Endocytosis in Muscle Cells
via
GSK3α-Dyn2-Bin1 Interplay
Insulin Signaling Attenuates GLUT4 Endocytosis in Muscle Cells
via
GSK3α-Dyn2-Bin1 Interplay
Abstract
Insulin-induced translocation of glucose transporter 4 (GLUT4) to the plasma membrane of skeletal muscle is critical for postprandial gl...

